In a story that blends heartbreak, courage, and hope, Jesy Nelson, the Little Mix star, has turned her personal tragedy into a campaign with the power to save lives. After her twins, Ocean Jade and Story Monroe Nelson, were diagnosed with spinal muscular atrophy (SMA), Jesy has fought tirelessly to ensure that future babies born in England will have the chance to be screened for this devastating genetic condition.
SMA is a ruthless disease, causing progressive muscle wastage, movement difficulties, breathing and swallowing challenges, muscle tremors, and even bone and joint problems. For Jesy and her family, the diagnosis in May 2025 brought a sobering reality: her precious twins are unlikely to walk or fully regain neck strength. Yet, in the face of immense personal pain, Jesy has transformed grief into advocacy, demanding a system where early diagnosis can make all the difference.
As part of a groundbreaking initiative, around 755,000 newborns across England will now be screened for SMA through a new study led by Professor Laurent Servais at the University of Oxford. Funded by the National Institute for Health and Care Research (NIHR), the programme aims to evaluate whether SMA should be added to routine newborn blood spot tests — the same heel-prick test given to babies nationwide. The study will cover seven NHS newborn screening laboratories, encompassing roughly two-thirds of births in England, and is set to begin in August.
Professor Servais described the initiative as “a decisive step towards ensuring that every child born with SMA in the UK has the opportunity to be diagnosed and treated before irreversible damage occurs.” He added, “We now have therapies that can fundamentally change the trajectory of this disease if we can identify affected infants early. Our goal is to provide the evidence needed to support the introduction of SMA into routine newborn screening nationwide, ensuring equitable access for all families.”
The campaign’s emotional weight is amplified by Jesy’s hands-on involvement. She has met with Health Secretary Wes Streeting, visited 10 Downing Street, and launched a petition calling for SMA screening to be added to post-birth checks — a petition that has now amassed more than 100,000 signatures. Her advocacy is personal, urgent, and symbolically powerful: for Jesy, this fight is about ensuring no family has to face the helplessness that she endured.
Giles Lomax, chief executive of SMA UK, emphasised the stakes: “For families affected by SMA, time is everything. A diagnosis through newborn screening can mean the difference between a life limited by severe disability and one with far greater independence and opportunity. This study brings us closer to a future where no child misses that critical window for treatment.”
The study, which will roll out in phases to allow researchers to compare outcomes between screened and unscreened babies, is expected to provide final results in 2031. In the meantime, Jesy’s campaign has ignited hope and awareness, shining a spotlight on a condition that, until now, has gone largely undetected in newborns.
Jesy Nelson’s story is one of resilience, courage, and the transformative power of advocacy. From the heartbreak of her twins’ SMA diagnosis to the national campaign that will impact hundreds of thousands of lives, she has turned personal pain into a life-saving legacy — ensuring that future families may never have to face the uncertainty and fear that once engulfed her own.
This is more than a celebrity campaign; it is a testament to how one parent’s fight can change the course of public health, offering hope where there was once despair, and rewriting the narrative for thousands of newborns across England.
